SCHEMBL4442002

SCHEMBL4442002

CC(=O)OC1=Cc2ccccc2C1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOA P21397 1/20 0.45
MAOB P27338 1/20 0.45
MTNR1A P48039 1/20 0.43
MTNR1B P49286 1/20 0.43
PTGS2 P35354 3/20 0.39
LMNA P02545 1/20 0.37
ALDH1A1 P00352 4/20 0.37
ELANE P08246 1/20 0.37
KDM4E B2RXH2 1/20 0.37
ESR1 P03372 1/20 0.37
ITGB3 P05106 1/20 0.37
ITGA2B P08514 1/20 0.37
HMGB1 P09429 1/20 0.37
HPGD P15428 1/20 0.37
TSHR P16473 1/20 0.37
GGT1 P19440 1/20 0.37
PTGS1 P23219 1/20 0.37
BLM P54132 1/20 0.37
NAPRT Q6XQN6 1/20 0.37
HSD17B10 Q99714 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30661164 0.84 MEN1 (0.39) MAOAMAOBMTNR1AMTNR1BPTGS2
SCHEMBL9798491 0.84 MEN1 (0.39) MAOAMAOBMTNR1AMTNR1BPTGS2
SCHEMBL1067728 0.84 MAOA (0.50) MAOAMAOBMTNR1AMTNR1BPTGS2
SCHEMBL2945418 0.75 ALDH1A1 (0.37) PTGS2LMNAALDH1A1ELANEKDM4E
SCHEMBL8031056 0.75 PTGS2 (0.53) MAOAMAOBMTNR1AMTNR1BPTGS2
SCHEMBL7080281 0.75 ALOX5 (0.50) MAOAMAOBMTNR1APTGS2ALDH1A1
SCHEMBL31564112 0.74
SCHEMBL29049090 0.72 CD69 (0.53) MAOAMAOBMTNR1AMTNR1BALDH1A1
SCHEMBL11556904 0.72 MAOA (0.49) MAOAMAOBMTNR1AMTNR1BPTGS2
SCHEMBL30586108 0.71 GPR84 (0.45) MAOAMAOBMTNR1AMTNR1BPTGS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4008708-A1 FULLERENE DERIVATIVES FOR ORGANIC SEMICONDUCTORS Nano-C, Inc. (US) 2022-06-08 EP disclosed
EP-3157895-B1 FULLERENE DERIVATIVES FOR ORGANIC SEMICONDUCTORS NANO C INC (US) 2021-12-29 EP disclosed
US-10374162-B2 Fullerene derivatives MERCK PATENT GMBH (DE) 2019-08-06 US disclosed
US-20170092866-A1 FULLERENE DERIVATIVES MERCK PATENT GMBH (DE) 2017-03-30 US disclosed
US-20170092866-A1 FULLERENE DERIVATIVES MERCK PATENT GMBH (DE) 2017-03-30 US disclosed
WO-2015192942-A1 FULLERENE DERIVATIVES MERCK PATENT GMBH (DE) 2015-12-23 WO disclosed
EP-2028198-A1 Propylene polymer and composition containing the same, molded object and laminate comprising these, and processes for producing propylene polymer and composition containinig the same Idemitsu Kosan Co., Ltd. (JP) 2009-02-25 EP disclosed
EP-2028199-A1 Propylene polymer and composition containing the same, molded object and laminate comprising these, and processes for producing propylene polymer and composition containinig the same Idemitsu Kosan Co., Ltd. (JP) 2009-02-25 EP disclosed
EP-1873172-A2 Propylene polymer and composition containing the same, molded object and laminate comprising these, and processes for producing propylene polymer and composition containing the same Idemitsu Kosan Co., Ltd. (JP) 2008-01-02 EP disclosed
EP-1867662-A2 Propylene polymer and composition containing the same, molded object and laminate comprising these, and processes for producing propylene polymer and composition containing the same Idemitsu Kosan Co., Ltd. (JP) 2007-12-19 EP disclosed
EP-1867663-A2 Propylene polymer and composition containing the same, molded object and laminate comprising these, and processes for producing propylene polymer and composition containing the same Idemitsu Kosan Co., Ltd. (JP) 2007-12-19 EP disclosed
EP-1865005-A2 Propylene polymer and composition containing the same, molded object and laminate comprising these, and processes for producing propylene polymer and composition containing the same Idemitsu Kosan Co., Ltd. (JP) 2007-12-12 EP disclosed
EP-1865006-A2 Propylene polymer and composition containing the same, molded object and laminate comprising these, and processes for producing propylene polymer and composition containing the same Idemitsu Kosan Co., Ltd. (JP) 2007-12-12 EP disclosed
EP-1865007-A2 Propylene polymer and composition containing the same, molded object and laminate comprising these, and processes for producing propylene polymer and composition containing the same Idemitsu Kosan Co., Ltd. (JP) 2007-12-12 EP disclosed
EP-1772467-A1 Propylene polymer and composition containing the same, molded object and laminate comprising these, and processes for producing propylene polymer and composition containing the same IDEMITSU KOSAN CO., LTD. (JP) 2007-04-11 EP disclosed
US-7199202-B2 Propylene polymer and composition containing the same, molded object and laminate comprising these, and processes for producing propylene polymer and composition containing the same IDEMITSU KOSAN CO. LTD. (JP) 2007-04-03 US disclosed
CN-1756746-A 6-substituted nicotinamide derivatives as opioid receptor antagonists LILLY CO ELI (US) 2006-04-05 CN disclosed
US-6906155-B1 Propylene polymer and composition containing the same, molded object and laminate comprising these, and processes for producing propylene polymer and composition containing the same IDEMITSU PETROCHEMICAL CO., LTD. (JP) 2005-06-14 US disclosed
US-20050043495-A1 Propylene polymer and composition containing the same, molded object and laminate comprising these, and processes for producing propylene polymer and composition containing the same IDEMITSU PETROCHEMICAL CO., LTD. (JP) 2005-02-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10374162-B2 Fullerene derivatives CFD, OCIAD2, PPOX MAOA 1721/4885MAOB 1585/4885MTNR1A 4456/4885
US-20170092866-A1 FULLERENE DERIVATIVES CFD, OCIAD2, PPOX MAOA 1721/4885MAOB 1585/4885MTNR1A 4456/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.